![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, May 12, 2020 3:31:10 PM
It's very possible some to receive the drug have passed on, it's practically impossible to cure all who've been hit with the disease. Many of those on ventilators have serious health conditions before ever getting covid-19. I believe anything that saves 50% or more of ventilator patients would be considered nearly a miracle, and thus far we're doing much better than that.
I really wish we could see what happens when the drug is given to newly diagnosed pneumonia patients, but that won't happen until it's been tried on those who're much sicker. I'm of the believe that a lighter dose in a healthier patient may be all that's needed to quickly cure the pneumonia. I don't know how many patients might be treated with a single vial of the medicine, but even if it's just a few, it would greatly lower the cost, and keeping people out of the hospital would certainly prove cost effective.
Gary
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM